European Archives - Page 167 of 1448 - European Medical Journal

hair loss

Tamoxifen Linked to Lasting Hair Loss After Chemotherapy

Tamoxifen treatment may reduce the effectiveness of scalp cooling, leading to persistent hair loss after chemotherapy.

Diabetes Subgroups Show Distinct Clinical and Metabolic Profiles

Diabetes Subgroups Show Distinct Clinical and Metabolic Profiles

A major review of nearly 60,000 cases shows new diabetes subgroups could transform diagnosis and treatment through more personalised care approaches.

Allergic Rhinitis and Optic Neuritis Link Uncovered

Allergic Rhinitis and Optic Neuritis Link Uncovered

The relationship between allergic rhinitis and optic neuritis appears to involve shared inflammatory pathways.

prostate cancer medicine

Combination Therapy Improves Survival in Metastatic Prostate Cancer

Largest real-world study shows ADT + ARPI improves persistence and survival in metastatic hormone-sensitive prostate cancer.

heart failure test

Groundbreaking Saliva Test for Detecting Heart Failure

Scientists develop a saliva-based heart failure test that promises faster, cheaper, and more accurate diagnosis.

HIV reservoir

Gut Bacteriome Influences HIV Reservoir Size and Activity

Gut bacteria influence HIV reservoir size and activity differently across GI segments, offering insights for targeted cure strategies.

ESMO 2025: Expanding treatment options in mHSPC

Join leading prostate cancer experts, Prof. Kim Chi (Canada), Prof. Nick James (UK), and Prof. Bertrand Tombal at ESMO 2025 in Berlin to…

finding Spinal Tumour

MRI Radiomics Model Enhances Prognostic Prediction in Spinal Tumours

MRI-based nested habitat radiomics improves prediction of progression-free survival in spinal tumours, highlighting aggressive tumour subregions.

brain damage in rugby players

Study Reveals Brain Damage in Rugby Players

Researchers find early signs of brain damage in rugby players through advanced imaging and biomarker analysis.

50 states of the US

Novo and Lilly agree to cut obesity drug costs in US

Novo Nordisk and Eli Lilly have made deals with President Trump to make their obesity medicines cheaper and easier to obtain in the US.